Correction to: Cancer Chemother Pharmacol (2008) 62:769–778 https://doi.org/10.1007/s00280-007-0662-x
The corresponding author of the original article has informed us of concerns about the immunoblots in Fig. 2 which were carried out in the collaborating laboratory of Professor Ann Jackman. The experiment has been replicated twice in the Workman laboratory and the findings remain the same. The authors have provided the original blots and the corrected version for Fig. 2 and this has been included in the latest online HTML and PDF versions of the article. The change does not affect the Figure Legend or main text of the article. The authors regret this error.
About this article
Cite this article
Banerji, U., Sain, N., Sharp, S.Y. et al. Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models. Cancer Chemother Pharmacol 82, 911–912 (2018). https://doi.org/10.1007/s00280-018-3674-9